Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-09

Clinical Trial Update: A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144) [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing famotidine chewable tablets to film-coated tablets has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pepcid (famotidine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Heartburn | Phase 1 | Status: COMPLETED | Results posted: 2015-12-09